Core Viewpoint - Akanda Corp. has announced a Share Exchange Agreement with First Towers & Fiber Corp, focusing on expanding its telecommunications infrastructure in Mexico while discontinuing its cannabis distribution business in the UK [2][4][12]. Company Overview - Akanda Corp. is an international cannabis company dedicated to cultivating and distributing high-quality medical cannabis and wellness products [20]. - First Towers specializes in telecommunications infrastructure development in Mexico, operating a 700+ km fiber optic network and focusing on expanding its services to other Latin American countries [6][9]. Transaction Details - The Share Exchange Agreement will result in First Towers shareholders receiving one share of Akanda for every 2.5 shares held, totaling approximately 15.3 million shares, with an additional US$14.1 million payable 18 months post-transaction [4][5]. - Upon closing, First Towers shareholders are expected to own approximately 83.1% of the combined company [5]. Market Opportunity - The telecommunications industry in Latin America is valued at approximately US$81 billion, with Mexico being the second-largest market [7]. - There is a significant demand for new wireless towers in Mexico, with First Towers estimating that several thousand towers are needed to achieve 4G LTE coverage for 96.4% of the population [8][15]. - An estimated 244 million people in Latin America lack internet access, presenting a substantial opportunity for 5G network deployment, projected to develop into a market exceeding US$21 billion annually [10]. Business Strategy - Akanda Corp. plans to focus on the growth of its pre-revenue Canadian farming property in British Columbia, where it intends to develop THC and CBD facilities [13]. - The decision to cease operations in the UK was influenced by challenges in management and the cost-effectiveness of maintaining the business in light of projected revenues [12].

Core Points - Akanda Corp. announced a 1-for-2 reverse stock split effective November 14, 2024, which was approved by shareholders on March 22, 2024, and the Board of Directors on October 25, 2024 [1][2] - The reverse stock split will reduce the number of outstanding common shares from approximately 4.1 million to approximately 2.0 million, without altering shareholders' percentage interests, except for fractional shares adjustments [2][3] - Vstock Transfer will act as the exchange agent for the reverse stock split, providing instructions to shareholders regarding the exchange of stock certificates [4] Company Overview - Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company focused on providing premium quality medical cannabis products globally [6] - The company is in an early stage of growth, with a limited operating history and minimal revenues to date, aiming to expand its operations and sales channels in international markets, particularly in the United Kingdom [6]

Core Viewpoint - Akanda Corp. has successfully closed an underwritten public offering, raising gross proceeds of $1,500,000 to support various corporate initiatives [2][3]. Group 1: Offering Details - The offering included 258,940 common shares priced at $1.00 each and 1,241,060 pre-funded warrants, which are immediately exercisable at a price of $0.0001 per share [2][3]. - The closing of the issuance occurred on October 3, 2024, under an underwriting agreement with Univest Securities, LLC [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated for capital expenditures, operating capacity, working capital, potential milestone payments for a Canadian property purchase option, general corporate purposes, and refinancing existing debt [3]. Group 3: Company Overview - Akanda Corp. is an international medical cannabis company focused on cultivating and distributing high-quality cannabis and wellness products across Europe and North America [5]. - The company's mission emphasizes providing safe, reliable, and accessible cannabis products while promoting sustainable business practices [5].

Core Points - Akanda Corp. has announced a public offering of 1,500,000 common shares at a price of $1.00 per share, with gross proceeds estimated at approximately $1,500,000 before expenses [2][3] - The offering is expected to close on about October 3, 2024, pending customary closing conditions [3] - The net proceeds will be used for capital expenditures, operating capacity, working capital, potential milestone payments for a Canadian property, general corporate purposes, and refinancing existing debt [3] Company Overview - Akanda Corp. is an international medical cannabis company operating in Europe and North America, focused on cultivating and distributing high-quality medical cannabis and wellness products [5] - The company's mission is to provide safe, reliable, and accessible cannabis products while promoting sustainable business practices [5]

Group 1 - Akanda Corp. has secured a hemp cultivation license in Canada, which is linked to a prior agreement with 1107385 B.C. LTD, enhancing its strategic initiatives in the Canadian cannabis market [2] - This development underscores Akanda's commitment to its strategic vision and aims to solidify its position as a leader in the global cannabis industry [2] Group 2 - Akanda is an international medical cannabis and wellness platform, focused on improving access to high-quality and affordable products [3] - The company's portfolio includes CanMart, a fully licensed pharmaceutical importer and distributor in the UK, supplying pharmacies and clinics [3] - Akanda has acquired rights to develop a farming property in British Columbia, which will include THC and cannabinoid (CBD) facilities [3]

Group 1 - Akanda (NASDAQ:AKAN) stock is experiencing a significant rise with over 6.8 million shares traded, far exceeding its daily average of approximately 1.3 million shares and its float of 760,620 units [1] - The increase in trading volume occurs without any clear news or announcements from Akanda, including no press releases or SEC filings, and there is no analyst coverage contributing to the rally [1] - AKAN is classified as a penny stock, with a prior closing price of $1.45 and a market capitalization of $2.779 million [1] Group 2 - AKAN stock has risen by 34.1% as of Friday morning, but investors are advised to be cautious due to the lack of news and the sudden surge in trading volume, which may indicate a pump and dump scenario [2] - The current situation makes AKAN stock a risky investment, prompting investors to be careful about acquiring shares in the company [2]

Core Points - Akanda Corporation has completed sales of its securities under an existing Form F-3 shelf registration, raising approximately $4.98 million in gross proceeds since its effectiveness on January 29, 2024 [2][3]. - The company has maxed out its $5 million capacity under the F-3 shelf registration and will not raise further funds under this statement, indicating future offerings will require a new registration statement [3]. Company Overview - Akanda is an international medical cannabis and wellness platform focused on improving access to high-quality and affordable products [4]. - The company's portfolio includes CanMart, a UK-based licensed pharmaceutical importer and distributor, and partnerships with Cellen Life Sciences' Leva Clinic, a digital pain clinic in the UK [4]. - Akanda has acquired rights to develop a farming property in British Columbia for THC and cannabinoid (CBD) facilities [4].

Core Points - Akanda Corp has regained compliance with Nasdaq's Minimum Bid Price Requirement as of June 7, 2024, after meeting the necessary criteria for 10 consecutive business days [2][3]. Company Overview - Akanda Corp is an international medical cannabis company focused on improving access to high-quality and affordable products. Its portfolio includes CanMart, a licensed pharmaceutical importer and distributor in the UK, and partnerships with Cellen Life Sciences' Leva Clinic, a digital pain clinic [4]. - The company is also developing a Canadian farming property in British Columbia for THC and cannabinoid (CBD) production [4].

Akanda (NASDAQ:AKAN) stock is rocketing higher on Friday alongside heavy pre-market trading of the cannabis company’s shares.This has more than 6.3 million shares of AKAN stock changing hands as of this writing. That’s a massive increase over its daily average trading volume of about 590,000 shares.While there’s no news from Akanda today, the company did enact a reverse stock split yesterday. That saw it combine shares on a one-for-40 basis. The company enacted this reverse stock split to boost the price of ...

London, United Kingdom--(Newsfile Corp. - May 21, 2024) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company"), an international medical cannabis company, reported that it expects to implement a 1-for-40 reverse stock split on its ordinary shares effective May 23, 2024, with trading to begin on a split-adjusted basis at the market open on that day. Trading in the ordinary shares will continue on The Nasdaq Capital Market under the symbol "AKAN". The new CUSIP number for the ordinary shares following the ...